Published in Blood Weekly, February 5th, 2004
"Positive selected hematopoietic stem cells are increasingly used for allogeneic transplantation with the CD34 antigen employed in most separation techniques," hematologists in Germany explained. "However, the recently described pentaspan molecule CD133 appears to be a marker of more primitive hematopoietic progenitors."
P. Lang and colleagues at the University of Tubingen described their "experience with a new CD133-based selection method in 10 pediatric patients with matched unrelated (n=2) or mismatched-related donors (n=8)."
"These patients received a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.